Valuation : Xcell Therapeutics Inc.

Market Cap 1.76TCr 1.31Cr 1.13Cr 1.07Cr 96.93L 1.82Cr 125.23Cr 1.83Cr 13Cr 4.88Cr 64Cr 4.92Cr 4.81Cr 201.32Cr P/E 2024
-4.26x
P/E 2025 -1.77x
Enterprise Value 1.62TCr 1.2Cr 1.04Cr 98.3L 89.1L 1.67Cr 115.12Cr 1.68Cr 12Cr 4.49Cr 59Cr 4.53Cr 4.43Cr 185.06Cr EV / Sales 2024
21.3x
EV / Sales 2025 14x
Free-Float
88.23%
Yield 2024 *
-
Yield 2025 -
1 day+1.60%
1 week-8.14%
Current month-14.77%
1 month-26.59%
3 months-29.93%
6 months-27.43%
Current year-38.83%
1 week 964
Extreme 964
1,125
1 month 964
Extreme 964
1,482
Current year 964
Extreme 964
2,050
1 year 964
Extreme 964
4,035
3 years 964
Extreme 964
12,900
5 years 964
Extreme 964
12,900
10 years 964
Extreme 964
12,900
Manager TitleAgeSince
Chief Executive Officer 54 01/09/2016
Chief Operating Officer 65 -
Chief Tech/Sci/R&D Officer 40 -
Director TitleAgeSince
Director/Board Member 54 01/09/2016
Director/Board Member 40 -
Director/Board Member 56 -
Change 5-day change 1-year change 3-year change Capi.($)
+1.60%-8.14%-63.97% - 1.31Cr
-0.65%-2.93%+47.70%+86.17% 99TCr
-0.29%-3.51%+49.15%+62.35% 64TCr
+0.83%+0.26%+17.76%+72.25% 45TCr
-0.38%-3.59%+30.13%+35.17% 34TCr
-0.09%-13.54%+13.34%+24.95% 26TCr
-0.43%-2.48%-0.73%+9.58% 25TCr
-1.34%-13.70%+36.53%+44.96% 20TCr
-3.44%-7.51%-20.63%-59.44% 19TCr
-0.75%-4.82%+25.46%+87.14% 18TCr
Average -0.49%-5.99%+13.48%+40.35% 35.05TCr
Weighted average by Cap. -0.51%-4.42%+30.96%+54.95%

Financials

2024 2025
Net sales 193.43Cr 14.43L 12.43L 11.77L 10.67L 20.02L 14Cr 20.12L 1.4Cr 53.77L 7.01Cr 54.2L 53.01L 22Cr 194.9Cr 14.54L 12.53L 11.86L 10.75L 20.17L 14Cr 20.27L 1.41Cr 54.18L 7.07Cr 54.61L 53.41L 22Cr
Net income -954.32Cr -71.19L -61.34L -58.08L -52.64L -98.77L -68Cr -99.27L -6.9Cr -2.65Cr -35Cr -2.67Cr -2.62Cr -109.34Cr -1.09TCr -81.52L -70.24L -66.5L -60.28L -1.13Cr -78Cr -1.14Cr -7.9Cr -3.04Cr -40Cr -3.06Cr -2.99Cr -125.2Cr
Net Debt -310.03Cr -23.13L -19.93L -18.87L -17.1L -32.09L -22Cr -32.25L -2.24Cr -86.18L -11Cr -86.86L -84.96L -36Cr -141.94Cr -10.59L -9L -9L -8L -14.69L -10Cr -14.76L -1.03Cr -39.45L -5.15Cr -39.77L -38.9L -16Cr
Logo Xcell Therapeutics Inc.
XCell Therapeutics Inc is a Korea-based company primarily engaged in the manufacture and distribution of cell culture mediums. The Company is mainly engaged in the provision of dermal papilla cells (DPC), keratinocytes, exosomes and other dedicated mediums. Additionally, the Company is engaged in the manufacture and distribution of virus transport mediums. The Company sells its products in domestic and overseas markets.
Employees
-
Date Price Change Volume
11/26/11 ₩1,016.00 +1.60% 45,875
10/26/10 ₩1,000.00 0.00% 53,605
09/26/09 ₩1,000.00 -1.67% 2,31,727
08/26/08 ₩1,017.00 -7.96% 4,56,900
07/26/07 ₩1,105.00 -0.09% 1,03,811
  1. Stock Market
  2. Stocks
  3. A373110 Stock
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!